PU-WS13 (this product is discontinued due to commercial reason) is a novel, potent, and selective Grp94/Hsp90 inhibitor (EC50 of 0.22 μM) belonging to the purine scaffold class. PU-WS13 has been shown to reduce the viability of breast cancer cells that express high levels of cell surface HER2 and the viability of human multiple myeloma cells in vitro.

纯度：≥98%

CAS：1454619-14-7